RMED RA Medical Systems Inc upside potentialRa Medical Systems, Inc. engages in the design, development, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases.
They have a debt of 56.957M, but also a small market cap of 11.314M.
6/12/2020 Richard Mejia Jr Director Buys 50,000 shares
5/29/2020 William R Enquist Director Buys 50,000 shares
You can double your money quite fast.
Not trading advice.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
Buysellsignal
BIOL Biolase upside potentialBIOLASE, Inc. is a medical device company, which engages in developing, manufacturing, marketing and sale of laser systems in dentistry and medicine.
MITCHELL KOPIN REPORTS 9.6% PASSIVE STAKE IN BIOLASE INC AS OF JULY 22
Armistice Capital Reports 9.99% Passive Stake In Biolase Inc As Of July 21
JACK W. SCHULER REPORTS A 20.54% STAKE IN BIOLASE INC AS OF JUNE 8, 2020
JACK W. SCHULER PREVIOUSLY HELD A 31.17% STAKE IN BIOLASE INC AS OF MAY 13, 2020
4/29/2020 Perkins Capital Management Inc. 1,381,000 $0.52M 0.6% +4.7% 4.373%
2/13/2020 Archon Capital Management LLC 2,675,427 $1.48M 0.3% +61.6% 8.645%
You still have time to take this huge buying opportunity!
Not trading advice.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
Would you buy this? ACHV Look at the volume!On July 31th : Achieve Life Sciences receives U.S. patent for its novel analogs of cytisinicline for use in prevention or treatment of CNS and addictive disorders.
Aimed at regaining compliance with Nasdaq's $1 minimum bid price listing requirement, Achieve Life Sciences has executed a 1:20 reverse split of its common stock.
Achieve Life Sciences is scheduled to be releasing its earnings data after the market closes on Thursday, August 6th. Analysts expect Achieve Life Sciences to post earnings of ($0.19) per share for the quarter.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
Siemens Healthineers buys US cancer therapy company Varian $16BGermany-based Siemens Healthineers said Sunday it will buy U.S. cancer therapy and research company Varian in a deal worth around $16.4 billion.
Siemens Healthineers SHL, -5.32%, in which industrial conglomerate Siemens holds a majority stake, said it will buy all shares in Varian Medical Systems, Inc. VAR, +3.18% for $177.50 per share in cash.
It said that the acquisition is expected to close in the first half of 2021, and requires the approval of regulators and Varian shareholders. Varian’s board of directors unanimously approved the agreement, it added.
Palo Alto, California-based Varian had revenues in the 2019 fiscal year of $3.2 billion, Siemens Healthineers said in a statement. Varian says it employs about 10,000 people around the world.
Siemens Healthineers said it plans to finance the acquisition with a mix of debt and equity.
Source: MarketWatch
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
B2GOLD CORP upside potentialB2Gold Corp. is an exploration company. The firm engages in the acquisition and development of mineral properties.
B2GOLD REPORTS QUARTERLY GOLD PRODUCTION OF 241,593 OZ AND RECORD QUARTERLY REVENUE OF $442 M FOR Q2 2020; ON TRACK TO MEET ANNUAL PRODUCTION GUIDANCE OF 1,000,000 TO 1,055,000 OZ
On 7/20/2020 Scotiabank Boosted Price Target to Outperform from $8.50 to $9.00
It`s in the overbought RSI area, we can expect a small bounce before another leg up.
B2Gold pays an annual dividend of $0.08 per share, with a dividend yield of 1.16%.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
RNO Renault ready for 40% gains (29 EUR)On 7/30/2020 both JPMorgan Chase & Co. and Goldman Sachs Group Set Price Target for RNO stocks to €29.00.
If you are interested in an indicator which can deliver accurate buy and sell at a beginning of a candle, not the end of it, like most do, just give me a PM for a trial period. Can be used in every market.
RSR Reserve Rights Fib Retracement levels to watchRSR Reserve Rights have a dangerous low Circulating Supply of 6,849,999,000 RSR from a total supply of 100,000,000,000 RSR so do the math what will happen to the price when all the supply hits the market.
For short term my target is at Fib 0.618 (7395 satoshi) for RSR, but in time can go even lower.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
WDI Wirecard insider buy? Why 68% in pre-exchange trading?!First of all Wirecard stock jumps up to 68 percent in pre-exchange trading at the beginning of the week. The reason for this is progress in the search for investors. According to insolvency administrator Michael Jaffé, 77 interested parties have signed confidentiality agreements for the core business: "We are confident that we will find an investor for the core business that offers significant entrepreneurial opportunities in an enormously growing market for an investor."
Second, reports say that someone bought 1 mil euro worth of shares, maybe it was an insider buy who knows the deal Wirecard is about to make.
In third place it`s Angela Merkel, the Chancellor of Germany who promoted Wirecard in China before the scandal, she somehow co-signed for Wirecard by doing that. I think the German government won`t let its people who put their lifetime savings in WDI stock to loose all the money. They also gave money to Lufthansa, they will need to buy part of Wirecard too. For sure they want a piece of that financial working business.
Wirecard has Assets of 5.85Bil Euro and Liabilities of 3.93Bil, so a nice debt to assets of 67%.
We will see a bounce sooner than expected.
Not trading advice.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
FISV Fiserv Upside Potential 25% gainFiserv, Inc. engages in the provision of financial services technology. It operates through the Payments, Financial, and Corporate and Other segments. The Payments segment primarily provides electronic bill payment and presentment services, internet and mobile banking software and services, account-to-account transfers, person-to-person payment services, debit and credit card processing and services, payments infrastructure services, and other electronic payments software and services.
The company is expected to report second-quarter earnings per share (EPS) of $0.93 and revenue of $3.32 billion on August 5. Goldman has a Conviction-Buy $125 price target on the company’s stock.
Robert W. Baird Boost Price Target to Outperform targeting $134.00 ➝ $135.00
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
CHEK Check-Cap upside potential - huge volume!Check-Cap Ltd. is a clinical stage medical diagnostics company engaging in the development of ingestible imaging capsule system for colorectal cancer screening.
Net Income $-13,840,000, but an encouraging Quick Ratio of 3.69.
Looking at the volume, this asset can double its price is seconds.
on 5/28/2020 HC Wainwright Reiterated Chek Rating to Buy and the target is $2.00.
Not trading advice.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
JAGX Would you buy something that was 10000x more expensive? Jaguar Health, Inc. is a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide.
July 20, 2020 : Jaguar Health, Inc. announced today that it has submitted to the U.S. Food and Drug Administration's Center for Veterinary Medicine the second-to-last required technical section to support approval of Jaguar's oral plant-based drug candidate Canalevia™ (crofelemer delayed-release tablets) to treat chemotherapy-induced diarrhea in dogs, although this filing was originally scheduled for submission by the end of August 2020.
More than 230,000 dogs in the U.S. receive chemotherapy treatment for various cancers each year, and roughly one in four (more than 50,000 dogs) will experience diarrhea as a side effect of treatment.
OASIS CAPITAL LLC REPORTS 9.99% PASSIVE STAKE IN JAGUAR HEALTH AS OF JULY 7- SEC FILING
Net Income $-38,540,000
Market Cap $42.15 million
Annual Sales $5.78 million
Debt-to-Equity Ratio 0.08
JAGX is a risky bet that can double your money in seconds.
Not trading advice.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
A very high buy opportunity the market will go back to topPlease share with me your thoughts about that,
This analysis based on the price action plus the strong resistance line,
Regards,
S&P Gameplay and the forecast for tomorrowWatch out the market and get ready to enter in a long position
RVVTF REVIVE THERAPEUTICS LTD upside potentialREVIVE THERAPEUTICS has a Market Capitalization of only 27.158M, while the Net Income (FY) reveals a debt, -1.028M.
Some analists predict an Average Target Price of 2.36 usd.
The indicators are bullish on most timeframes.
Still a lot of room to grow, with that huge volume.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, like others, just leave me a P.M.
LIACF AMERICAN LITHIUM CORP upside potentialWith a MARKET CAP of only 140.29M and a Net Income of -9.289M and growing economic demand for lithium-based technologies makes American Lithium maybe worth a shot, especially compared to some other penny stocks out there.
American Lithium Announces Maiden Pit-Constrained Mineral Resource of 5.37 Million Tonnes Lithium Carbonate Equivalent Measured and Indicated and 1.76 Million Tonnes Inferred.
American Lithium Corp. is an exploration stage company. It is engaged in the acquisition, exploration, and development of lithium deposits.
Looking at the charts, they show buy signals on most timeframes.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, like others, just leave me a P.M.
NKLA Nikola Corporation - the new Tesla? If the fuel of future cars will be hydrogen, then Nikola is already there, offering long miles hydrogen electric powertrains.
Nikola Motor Company is a pioneer in electric heavy duty applications. Nikola offers both pure electric and also hydrogen electric powertrains.
Nikola Badger EV pickup will debut at Nikola World 2020 in December offering 0-60 MPH in 2.9 Seconds and a Range of 600 Miles, 906 HP, 980 ft. lbs. of torque, 15 kilowatt power export with 220V and 110V.
Even though the Market Capitalization of 19.575B is high, investors continue to bet on the growth potential of electric transportation.
On 6/17/2020 Cowen brokerage Initiated Coverage to Outperform and put the target price at $79.00.
The indicators show a buy signal on most of the timeframes.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, like others, just leave me a P.M.
WCAGY WDI Time to reenter this trade | WirecardWith a Mkt cap of only 262.95M, once the pride of the german fintech, Wirecard has still room to grow if they manage to reestablish trust with a new board.
The indicators show a buy signal at the actual price.
Not trading advice.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, like others, just leave me a P.M.
10 yrTreasuries look to be signaling that yesterday & today are in fact buy the dip we have risk on sentiment coming next couple weeks.
If we check the weekly RSI 10 yr yields r very overbought, coincidentally so are all major indices RSI weekly indicators.
Conclusion is we are in the final chapters of the bull market since March and another crash is imminent. But will likely be another opportunity to buy the best dip before another massive bull market over the next few years.
TLRDOpened long here. Downside looks minimal with ATL around .88c and upside is massive. POC on Daily around $1.25 & Weekly POC $4.20 the trade looks good. I think the shake out is about complete as this stock got a lot of hype from Michael Burry being a large holder. I don't think $4.20 is on the table till Oct or there about with a large correction pending, but I do think $2.50-$3 is a reasonable TP. Stoch RSI oversold on all TFs except weekly which is currently putting in a HL on that RSI TF. I think 1-2 weeks we can hit my TP
VISA INC chart analysis:On one day chart price is forming new high on the peak.
Below 186.36 confirm bearish.
The price has Strong internal support 186.36 near this level.
The volume declining but though, it has more volume then normal.
As it has a support price can move up.
If the price cross the 202.34 level it can still further move up-to 208.54
